Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Bioactive peptide design using the Resonant Recognition Model.

Nonlinear biomedical physics

Cosic I, Pirogova E.
PMID: 17908333
Nonlinear Biomed Phys. 2007 Jul 19;1(1):7. doi: 10.1186/1753-4631-1-7.

With a large number of DNA and protein sequences already known, the crucial question is to find out how the biological function of these macromolecules is "written" in the sequence of nucleotides or amino acids. Biological processes in any...

Cite
Cosic I, Pirogova E. Bioactive peptide design using the Resonant Recognition Model. Nonlinear Biomed Phys. 2007;1(1):7doi: 10.1186/1753-4631-1-7.
Cosic, I., & Pirogova, E. (2007). Bioactive peptide design using the Resonant Recognition Model. Nonlinear biomedical physics, 1(1), 7. https://doi.org/10.1186/1753-4631-1-7
Cosic, Irena, and Pirogova, Elena. "Bioactive peptide design using the Resonant Recognition Model." Nonlinear biomedical physics vol. 1,1 (2007): 7. doi: https://doi.org/10.1186/1753-4631-1-7
Cosic I, Pirogova E. Bioactive peptide design using the Resonant Recognition Model. Nonlinear Biomed Phys. 2007 Jul 19;1(1):7. doi: 10.1186/1753-4631-1-7. PMID: 17908333; PMCID: PMC1997124.
Copy Download .nbib Format: NLM
Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.

Cancer research and treatment

Cho IC, Chung HS, Cho KS, Kim JE, Joung JY, Seo HK, Chung J, Park WS, Hong EK, Lee KH.
PMID: 20948921
Cancer Res Treat. 2010 Sep;42(3):157-62. doi: 10.4143/crt.2010.42.3.157. Epub 2010 Sep 30.

PURPOSE: The objective of this study was to determine Bcl-2 expression in localized prostate cancer and its potential role as a predictive factor for biochemical recurrence (BCR).MATERIALS AND METHODS: This study included 171 Korean patients with newly diagnosed adenocarcinoma...

Cite
Cho IC, Chung HS, Cho KS, et al. Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis. Cancer Res Treat. 2010;42(3):157-62doi: 10.4143/crt.2010.42.3.157.
Cho, I. C., Chung, H. S., Cho, K. S., Kim, J. E., Joung, J. Y., Seo, H. K., Chung, J., Park, W. S., Hong, E. K., & Lee, K. H. (2010). Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis. Cancer research and treatment, 42(3), 157-62. https://doi.org/10.4143/crt.2010.42.3.157
Cho, In-Chang, et al. "Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis." Cancer research and treatment vol. 42,3 (2010): 157-62. doi: https://doi.org/10.4143/crt.2010.42.3.157
Cho IC, Chung HS, Cho KS, Kim JE, Joung JY, Seo HK, Chung J, Park WS, Hong EK, Lee KH. Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis. Cancer Res Treat. 2010 Sep;42(3):157-62. doi: 10.4143/crt.2010.42.3.157. Epub 2010 Sep 30. PMID: 20948921; PMCID: PMC2953779.
Copy Download .nbib Format: NLM
The LIN28/let-7 Pathway in Cancer.

Frontiers in genetics

Balzeau J, Menezes MR, Cao S, Hagan JP.
PMID: 28400788
Front Genet. 2017 Mar 28;8:31. doi: 10.3389/fgene.2017.00031. eCollection 2017.

Among all tumor suppressor microRNAs, reduced let-7 expression occurs most frequently in cancer and typically correlates with poor prognosis. Activation of either LIN28A or LIN28B, two highly related RNA binding proteins (RBPs) and proto-oncogenes, is responsible for the global...

Cite
Balzeau J, Menezes MR, Cao S, et al. The LIN28/let-7 Pathway in Cancer. Front Genet. 2017;8:31doi: 10.3389/fgene.2017.00031.
Balzeau, J., Menezes, M. R., Cao, S., & Hagan, J. P. (2017). The LIN28/let-7 Pathway in Cancer. Frontiers in genetics, 831. https://doi.org/10.3389/fgene.2017.00031
Balzeau, Julien, et al. "The LIN28/let-7 Pathway in Cancer." Frontiers in genetics vol. 8 (2017): 31. doi: https://doi.org/10.3389/fgene.2017.00031
Balzeau J, Menezes MR, Cao S, Hagan JP. The LIN28/let-7 Pathway in Cancer. Front Genet. 2017 Mar 28;8:31. doi: 10.3389/fgene.2017.00031. eCollection 2017. PMID: 28400788; PMCID: PMC5368188.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries